Chlamydia persistence - a tool to dissect chlamydia-host interactions

Microbes and Infection

Volumn 13, Issue 7, 2011, Pages 649-662

  Schoborg, R V ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Aberrant body; Bacterial viral co infection; Chlamydiaceae; Chlamydial persistence; Sexually transmitted infection; Tissue tropism

Indexed keywords

GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 60; PENICILLIN G; PROTEIN P47; PURINERGIC RECEPTOR; RNA 16S;

BACTERIAL GROWTH; CHLAMYDIA; CHLAMYDIAL PNEUMONIA; CHLAMYDIASIS; DEVELOPMENTAL STAGE; DNA REPLICATION; DORMANCY; HELA CELL; HOST PARASITE INTERACTION; HUMAN; MIXED INFECTION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SMOKING; TROPISM;

CHLAMYDIA; CHLAMYDIACEAE; CHLAMYDIAE;

EID: 79957765658     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.03.004     Document Type: Short Survey

References (89)

1. Stephens R.S., Myers G., Eppinger M., Bavoil P.M. Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunol. Med. Microbiol. 2009, 55:115-119.
2. Wilson D.P., Timms P., McElwain D.L., Bavoil P.M. Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull. Math. Biol. 2006, 68:161-178.
3. Hybiske K., Stephens R.S. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11430-11435.
4. Galasso G.J., Manire G.P. Effect of antiserum and antibiotics on persistent infection of HeLa cells with meningopneumonitis virus. J. Immunol. 1961, 86:382-385.
5. Matsumoto A., Manire G.P. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 1970, 101:278-285.
6. Hogan R.J., Mathews S.A., Mukhopadhyay S., Summersgill J.T., Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect. Immun. 2004, 72:1843-1855.
7. Wyrick P.B. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 2010, 201(Suppl. 2):S88-S95.
8. Wiedeman J.A., Kaul R., Heuer L.S., Thao N.N., Pinkerton K.E., Wenman W.M. Tobacco smoke induces persistent infection of Chlamydophila pneumoniae in HEp-2 cells. Microb. Pathog. 2004, 37:141-148.
9. Pettengill M.A., Lam V.W., Ojcius D.M. The danger signal adenosine induces persistence of chlamydial infection through stimulation of A2b receptors. PLoS One 2009, 4:e8299.
10. Deka S., Vanover J., Dessus-Babus S., Whittimore J., Howett M.K., Wyrick P.B., Schoborg R.V. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell Microbiol. 2006, 8:149-162.
11. Borel N., Dumrese C., Ziegler U., Schifferli A., Kaiser C., Pospischil A. Mixed infections with Chlamydia and porcine epidemic diarrhea virus - a new in vitro model of chlamydial persistence. BMC Microbiol. 2010, 10:201.
12. Goellner S., Schubert E., Liebler-Tenorio E., Hotzel H., Saluz H.P., Sachse K. Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect. Immun. 2006, 74:4801-4808.
13. Mukhopadhyay S., Miller R.D., Sullivan E.D., Theodoropoulos C., Mathews S.A., Timms P., Summersgill J.T. Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun. 2006, 74:3853-3863.
14. Ouellette S.P., Hatch T.P., AbdelRahman Y.M., Rose L.A., Belland R.J., Byrne G.I. Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFN gamma-mediated host cell tryptophan starvation. Mol. Microbiol. 2006, 62:1387-1401.
15. Klos A., Thalmann J., Peters J., Gerard H.C., Hudson A.P. The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol. Lett. 2009, 291:120-126.
16. Timms P., Good D., Wan C., Theodoropoulos C., Mukhopadhyay S., Summersgill J., Mathews S. Differential transcriptional responses between the interferon-gamma-induction and iron-limitation models of persistence for Chlamydia pneumoniae. J. Microbiol. Immunol. Infect. 2009, 42:27-37.
17. Belland R.J., Nelson D.E., Virok D., Crane D.D., Hogan D., Sturdevant D., Beatty W.L., Caldwell H.D. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15971-15976.
18. Sueltenfuss E.A., Pollard M. Cytochemical assay of interferon produced by duck hepatitis virus. Science 1963, 139:595-596.
19. Byrne G.I., Lehmann L.K., Landry G.J. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 1986, 53:347-351.
20. Carlin J.M., Borden E.C., Byrne G.I. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon. Res. 1989, 9:329-337.
21. Rapoza P.A., Tahija S.G., Carlin J.P., Miller S.L., Padilla M.L., Byrne G.I. Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest. Ophthal. Vis. Sci. 1991, 32:2919-2923.
22. Beatty W.L., Belanger T.A., Desai A.A., Morrison R.P., Byrne G.I. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 1994, 62:3705-3711.
23. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3998-4002.
24. Rothermel C.D., Byrne G.I., Havell E.A. Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect. Immun. 1983, 39:362-370.
25. Beatty W.L., Morrison R.P., Byrne G.I. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect. Immun. 1995, 63:199-205.
26. McClarty G., Caldwell H.D., Nelson D.E. Chlamydial interferon gamma immune evasion influences infection tropism. Curr. Opin. Microbiol. 2007, 10:47-51.
27. Morrison R.P. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect. Immun. 2000, 68:6038-6040.
28. Shaw A.C., Christiansen G., Roepstorff P., Birkelund S. Genetic differences in the Chlamydia trachomatis tryptophan synthase alpha-subunit can explain variations in serovar pathogenesis. Microbes Infect. 2000, 2:581-592.
29. Fehlner-Gardiner C., Roshick C., Carlson J.H., Hughes S., Belland R.J., Caldwell H.D., McClarty G. Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J. Biol. Chem. 2002, 277:26893-26903.
30. Caldwell H.D., Wood H., Crane D., Bailey R., Jones R.B., Mabey D., Maclean I., Mohammed Z., Peeling R., Roshick C., Schachter J., Solomon A.W., Stamm W.E., Suchland R.J., Taylor L., West S.K., Quinn T.C., Belland R.J., McClarty G. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 2003, 111:1757-1769.
31. Perry L.L., Su H., Feilzer K., Messer R., Hughes S., Whitmire W., Caldwell H.D. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J. Immunol. 1999, 162:3541-3548.
32. Roshick C., Wood H., Caldwell H.D., McClarty G. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 2006, 74:225-238.
33. Nelson D.E., Virok D.P., Wood H., Roshick C., Johnson R.M., Whitmire W.M., Crane D.D., Steele-Mortimer O., Kari L., McClarty G., Caldwell H.D. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10658-10663.
34. Al-Zeer M.A., Al-Younes H.M., Braun P.R., Zerrahn J., Meyer T.F. IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS One 2009, 4:e4588.
35. Bernstein-Hanley I., Coers J., Balsara Z.R., Taylor G.A., Starnbach M.N., Dietrich W.F. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14092-14097.
36. Coers J., Bernstein-Hanley I., Grotsky D., Parvanova I., Howard J.C., Taylor G.A., Dietrich W.F., Starnbach M.N. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J. Immunol. 2008, 180:6237-6245.
37. Miyairi I., Tatireddigari V.R., Mahdi O.S., Rose L.A., Belland R.J., Lu L., Williams R.W., Byrne G.I. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J. Immunol. 2007, 179:1814-1824.
38. Vignola M.J., Kashatus D.F., Taylor G.A., Counter C.M., Valdivia R.H. cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis. J. Biol. Chem. 2010, 285:21625-21635.
39. Tietzel I., El-Haibi C., Carabeo R.A. Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One 2009, 4:e6499.
40. Robertson D.K., Gu L., Rowe R.K., Beatty W.L. Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog. 2009, 5:e1000664.
41. Nelson D.E., Taylor L.D., Shannon J.G., Whitmire W.M., Crane D.D., McClarty G., Su H., Kari L., Caldwell H.D. Phenotypic rescue of Chlamydia trachomatis growth in IFN-gamma treated mouse cells by irradiated Chlamydia muridarum. Cell Microbiol. 2007, 9:2289-2298.
42. Coutinho-Silva R., Correa G., Sater A.A., Ojcius D.M. The P2X(7) receptor and intracellular pathogens: a continuing struggle. Purinergic Signal 2009, 5:197-204.
43. Coutinho-Silva R., Perfettini J.L., Persechini P.M., Dautry-Varsat A., Ojcius D.M. Modulation of P2Z/P2X(7) receptor activity in macrophages infected with Chlamydia psittaci. Am. J. Physiol. Cell Physiol. 2001, 280:C81-C89.
44. Coutinho-Silva R., Stahl L., Raymond M.N., Jungas T., Verbeke P., Burnstock G., Darville T., Ojcius D.M. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 2003, 19:403-412.
45. Darville T., Welter-Stahl L., Cruz C., Sater A.A., Andrews C.W., Ojcius D.M. Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice. J. Immunol. 2007, 179:3707-3714.
46. Ulmann L., Hirbec H., Rassendren F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 2010, 29:2290-2300.
47. Alzola E., Perez-Etxebarria A., Kabre E., Fogarty D.J., Metioui M., Chaib N., Macarulla J.M., Matute C., Dehaye J.P., Marino A. Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. J. Biol. Chem. 1998, 273:30208-30217.
48. Paguirigan A.M., Byrne G.I., Becht S., Carlin J.M. Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect. Immun. 1994, 62:1131-1136.
49. Berger M., Schroder B., Daeschlein G., Schneider W., Busjahn A., Buchwalow I., Luft F.C., Haller H. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J. Lab. Clin. Med. 2000, 136:194-200.
50. Wiedeman J.A., Kaul R., Heuer L.S., Thao N.N., Pinkerton K.E., Wenman W.M. Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells. Microb. Pathog. 2005, 39:197-204.
51. Pryor W.A., Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N.Y. Acad. Sci. 1993, 686:12-27. (discussion 27-18).
52. Suzuki T., Mower H.F., Friesen M.D., Gilibert I., Sawa T., Ohshima H. Nitration and nitrosation of N-acetyl-l-tryptophan and tryptophan residues in proteins by various reactive nitrogen species. Free Radic. Biol. Med. 2004, 37:671-681.
53. Yasui H., Takai K., Yoshida R., Hayaishi O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:6622-6626.
54. Bauer C.M., Dewitte-Orr S.J., Hornby K.R., Zavitz C.C., Lichty B.D., Stampfli M.R., Mossman K.L. Cigarette smoke suppresses type I interferon-mediated antiviral immunity in lung fibroblast and epithelial cells. J. Interfer. Cytokine Res. 2008, 28:167-179.
55. Dhillon N.K., Murphy W.J., Filla M.B., Crespo A.J., Latham H.A., O'Brien-Ladner A. Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers. Toxicol. Appl. Pharmacol. 2009, 237:22-28.
56. Cicko S., Lucattelli M., Muller T., Lommatzsch M., De Cunto G., Cardini S., Sundas W., Grimm M., Zeiser R., Durk T., Zissel G., Boeynaems J.M., Sorichter S., Ferrari D., Di Virgilio F., Virchow J.C., Lungarella G., Idzko M. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J. Immunol. 2010, 185:688-697.
57. Lommatzsch M., Cicko S., Muller T., Lucattelli M., Bratke K., Stoll P., Grimm M., Durk T., Zissel G., Ferrari D., Di Virgilio F., Sorichter S., Lungarella G., Virchow J.C., Idzko M. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 181:928-934.
58. Wolf K., Hackstadt T. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell Microbiol. 2001, 3:145-152.
59. van Ooij C., Kalman L., van I., Nishijima M., Hanada K., Mostov K., Engel J.N. Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell Microbiol. 2000, 2:627-637.
60. Goldkorn T., Balaban N., Shannon M., Chea V., Matsukuma K., Gilchrist D., Wang H., Chan C. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J. Cell Sci. 1998, 111:3209-3220.
61. Castillo S.S., Levy M., Thaikoottathil J.V., Goldkorn T. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp. Cell Res. 2007, 313:2680-2686.
62. Levy M., Khan E., Careaga M., Goldkorn T. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 297:L125-L133.
63. Airenne S., Surcel H.M., Alakarppa H., Laitinen K., Paavonen J., Saikku P., Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 1999, 67:1445-1449.
64. Hatch G.M., McClarty G. Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell. Infect. Immun. 1998, 66:3727-3735.
65. Cocchiaro J.L., Kumar Y., Fischer E.R., Hackstadt T., Valdivia R.H. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9379-9384.
66. Murphy G., Rouse R.L., Polk W.W., Henk W.G., Barker S.A., Boudreaux M.J., Floyd Z.E., Penn A.L. Combustion-derived hydrocarbons localize to lipid droplets in respiratory cells. Am. J. Respir. Cell Mol. Biol. 2008, 38:532-540.
67. McCann M.F., Irwin D.E., Walton L.A., Hulka B.S., Morton J.L., Axelrad C.M. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 1992, 1:125-129.
68. Sasson I.M., Haley N.J., Hoffmann D., Wynder E.L., Hellberg D., Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N. Engl. J. Med. 1985, 312:315-316.
69. Zenzes M.T., Puy L.A., Bielecki R. Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. Mol. Hum. Reprod. 1998, 4:159-165.
70. Boffetta P., Jourenkova N., Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997, 8:444-472.
71. Pontefract R.D., Ng C.W., Bergeron G. Vero cells co-infected with Chlamydia trachomatis and herpes simplex virus type 2: a scanning and transmission electron microscope study. Sex Transm. Dis. 1989, 16:74-78.
72. Chiarini F., Mansi A., Pisani S., Seganti L., Brunori S., Gentile V., Di Silverio F. In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis. New Microbiol. 1996, 19:263-266.
73. Superti F., Longhi C., Di Biase A.M., Tinari A., Marchetti M., Pisani S., Gallinelli C., Chiarini F., Seganti L. Herpes simplex virus type 2 modulates the susceptibility of human bladder cells to uropathogenic bacteria. Med. Microbiol. Immunol. 2001, 189:201-208.
74. Deka S., Vanover J., Sun J., Kintner J., Whittimore J., Schoborg R.V. An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence. Cell Microbiol. 2007, 9:725-737.
75. Vanover J., Sun J., Deka S., Kintner J., Duffourc M.M., Schoborg R.V. Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Microbiology 2008, 154:971-978.
76. Vanover J., Kintner J., Whittimore J., Schoborg R.V. Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence. Microbiology 2010, 156:1294-1302.
77. Browne E.P., Wing B., Coleman D., Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 2001, 75:12319-12330.
78. Schoborg R.V., Sun J., Daniels C., Whittimore J., Kintner J. The host nectin-1 protein regulates chlamydial development. Proceedings of the 12th International Symposium on Human Chlamydial Infections 2010, 95-98. Hof bei Salzburg, Austria. J. Schachter, G. Byrne, H. Caldwell, M. Chernesky, I. Clarke, D. Mabey, J. Paavonen, P. Saikku, M. Starnbach, A. Stary, R. Stephens, P. Timms, P. Wyrick (Eds.).
79. Takai Y., Miyoshi J., Ikeda W., Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 2008, 9:603-615.
80. MacLeod I.J., Minson T. Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One 2010, 5:e9560.
81. Cheshenko N., Liu W., Satlin L.M., Herold B.C. Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. Mol. Biol. Cell 2007, 18:3119-3130.
82. Krummenacher C., Baribaud I., Sanzo J.F., Cohen G.H., Eisenberg R.J. Effects of herpes simplex virus on structure and function of nectin-1/HveC. J. Virol. 2002, 76:2424-2433.
83. Stuedli A., Grest P., Schiller I., Pospischil A. Mixed infections in vitro with different Chlamydiaceae strains and a cell culture adapted porcine epidemic diarrhea virus. Vet. Microbiol. 2005, 106:209-223.
84. Yoshikawa T., Hill T.E., Yoshikawa N., Popov V.L., Galindo C.L., Garner H.R., Peters C.J., Tseng C.T. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One 2010, 5:e8729.
85. Mosca J.D., Pitha P.M. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell Biol. 1986, 6:2279-2283.
86. Obojes K., Andres O., Kim K.S., Daubener W., Schneider-Schaulies J. Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J. Virol. 2005, 79:7768-7776.
87. Li B.X., Ge J.W., Li Y.J. Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virology 2007, 365:166-172.
88. Gabrilovac J., Breljak D., Cupic B., Ambriovic-Ristov A. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line. Life Sci. 2005, 76:2681-2697.
89. Pospischil A., Borel N., Chowdhury E.H., Guscetti F. Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis. Vet. Microbiol. 2009, 135:147-156.